Ulcerative colitis (strict definition, require KELA, min 2 HDR)

K11_UC_STRICT2

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions K11_KELAUC and K11_ULCERnumber of events >1	8123
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K51 Hospital discharge: ICD-9 — 556 Hospital discharge: ICD-8 — 5631\|569 Hospital discharge: excluded ICD-9 — 5564A Cause of death: ICD-10 — K51 Cause of death: ICD-9 — 556 Cause of death: ICD-8 — 5631\|569 Cause of death: excluded ICD-9 — 5564A 2 out of 7 registries used, show all original rules.	7439
4. Check minimum number of events None	7439
5. Include endpoints None	7439
6. Filter based on genotype QC (FinnGen only)	7439

Control definitions (FinnGen only)

Control conditions: not K11_KELAUC

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: K50-K52
Name in latin: Colitis ulcerosa

NAME	K11_UC_STRICT2
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!K11_KELAUC
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	K11_KELAUC&K11_ULCER_NEVT>1
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K51
HD_ICD_9	556
HD_ICD_8	5631\|569
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5564A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K51
COD_ICD_9	556
COD_ICD_8	5631\|569
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5564A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ulcerative colitis (strict definition, require KELA, min 2 HDR) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41969	18869	22911
Only index persons	39683	18151	21532
Unadjusted period prevalence (%)
Whole population	0.59	0.54	0.64
Only index persons	0.75	0.67	0.82
Median age at first event (years)
Whole population	37.32	36.03	38.27
Only index persons	36.56	35.57	37.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7439	3770	3669
Unadjusted period prevalence (%)	1.45	1.29	1.62
Median age at first event (years)	38.35	35.00	41.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6648: Matched controls
66479

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

+∞

323.0

322

J01MA02

ATC

ciprofloxacin; systemic

2.9

323.0

3079

15209

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.5

323.0

2865

9544

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

274.4

323.0

1788

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

561.6

323.0

322

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

6648

404

L04AX01

ATC

azathioprine; systemic

55.5

323.0

2818

870

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

364.5

323.0

4072

287

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

175.1

323.0

517

H02AB06

ATC

prednisolone; systemic

9.0

323.0

5259

19630

A07EC02

ATC

mesalazine; oral, rectal

1873.2

323.0

6326

694

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

341.7

323.0

936

L01BB02

ATC

mercaptopurine; oral

79.0

323.0

826

119

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

71.1

323.0

567

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

11.9

323.0

1788

1998

K50.1

ICD-10 Finland

Crohn disease of large intestine

34.2

323.0

599

192

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

811.2

323.0

2787

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

273.3

323.0

386

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

373.7

323.0

1266

K50.9

ICD-10 Finland

Crohn disease, unspecified

23.5

323.0

599

279

A07EA06

ATC

budesonide; oral, local oral

67.5

323.0

2375

543

K51.8

ICD-10 Finland

Other ulcerative colitis

280.3

323.0

1756

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

44.0

323.0

428

104

UJF32

NOMESCO Finland

Coloscopy

22.0

323.0

5003

8060

D94

ICPC

Chronic enteritis/ulcerative colitis

94.0

323.0

528

A07EA02

ATC

hydrocortisone; rectal

228.6

323.0

2590

185

H02AB07

ATC

prednisone; oral

6.4

323.0

2056

4340

K51

ICD-10 Finland

Ulcerative colitis

472.9

323.0

1114

K50.8

ICD-10 Finland

Other Crohn disease

22.3

323.0

598

294

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

11.2

323.0

826

832

K51.5

ICD-10 Finland

Left sided colitis

761.6

323.0

4278

155

A07EC01

ATC

sulfasalazine; oral, rectal

9.3

323.0

1697

2361

A07EA01

ATC

prednisolone; rectal

255.9

323.0

541

UJF30

NOMESCO Finland

Ileoscopy through colon

18.7

323.0

2800

2488

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

1621.0

312.6

302

P01AB01

ATC

metronidazole; oral, rectal

2.7

307.5

3169

16689

ZX120

NOMESCO Finland

Intravenous

4.8

297.0

1113

2688

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

281.1

264.9

269

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

517.2

252.5

250

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

250.2

2171

9991

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

96.0

249.4

276

K83.0

ICD-10 Finland

Cholangitis

21.3

241.6

364

180

A07EC03

ATC

olsalazine; oral

307.9

233.3

236

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

11.4

225.7

439

408

4AA12

NOMESCO Finland

61.3

176.9

208

A05AA02

ATC

ursodeoxycholic acid; oral

10.1

174.4

361

376

4AB02

NOMESCO Finland

49.7

174.0

212

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

30.3

172.4

234

L04AB04

ATC

adalimumab; parenteral

8.4

170.5

393

493

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

167.0

1578

7323

WX002

NOMESCO Finland

Sedation and analgesia

2.6

166.9

1458

6474

A02BC02

ATC

pantoprazole; systemic

2.0

165.6

4149

29772

K50.0

ICD-10 Finland

Crohn disease of small intestine

10.5

158.8

321

319

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

153.1

1612

7863

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

142.2

2666

16674

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.5

142.0

274

248

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

139.1

1393

6576

L04AD01

ATC

ciclosporin; systemic

7.4

126.5

314

440

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

425.6

126.3

126

1370

FHL

Colonoscopy, whole colon

34.2

119.5

157

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.0

118.4

750

2682

A07DA03

ATC

loperamide; oral

5.4

118.3

377

733

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

203.6

115.9

120

JFH10

NOMESCO Finland

Total colectomy and ileostomy

54.8

108.0

129

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.9

107.7

478

1296

UJF92

NOMESCO Finland

Capsular endoscopy

6.4

106.6

295

481

JFH11

NOMESCO Finland

Laparoscopic colectomy

531.3

106.0

105

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

139.8

103.4

110

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.3

103.4

408

993

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.6

103.2

513

1529

Z93.2

ICD-10 Finland

Ileostomy status

44.2

101.5

126

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

259.3

100.0

102

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

14.1

95.8

167

121

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.8

94.7

437

1223

253

Kela drug reimbursment

164.0

92.4

3042

Kela drug reimbursment

164.0

92.4

K92.1

ICD-10 Finland

Melaena

4.1

92.1

386

992

C05AA08

ATC

fluocortolone; rectal, topical

2.3

90.9

972

4637

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

90.1

778

3325

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.2

89.1

289

572

4AA33

NOMESCO Finland

105.9

86.1

JFF10

NOMESCO Finland

Loop enterostomy

16.9

82.7

134

3005

Kela drug reimbursment

Tofacitinib

29.2

82.2

112

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

92.3

82.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

80.4

367

1015

H02AB09

ATC

hydrocortisone; systemic

5.0

80.4

272

564

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.4

78.6

767

3481

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

10.8

74.6

147

139

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.6

72.4

221

407

K51.4

ICD-10 Finland

Inflammatory polyps

189.6

72.3

L04AB06

ATC

golimumab; parenteral

8.7

68.9

153

180

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.9

68.8

237

501

6419

FHL

Other measure in this category

84.3

67.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.6

66.2

239

531

3AC01

NOMESCO Finland

7.7

65.4

156

206

L04AA29

ATC

tofacitinib; oral

21.6

64.9

H02AB04

ATC

methylprednisolone; systemic

2.0

63.6

896

4763

L04AC05

ATC

ustekinumab; parenteral

13.5

62.2

110

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

61.5

N02BE01

ATC

paracetamol; systemic, rectal

1.7

61.5

5256

46246

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.6

60.8

185

340

A07AA09

ATC

vancomycin; oral

7.4

60.6

149

206

C10AC01

ATC

colestyramine; oral

4.3

59.3

231

553

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.7

59.2

155

235

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

5.6

58.2

177

325

UJK12

NOMESCO Finland

Peroral cholangioscopy

33.4

58.0

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

15.5

57.1

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

56.6

626

2992

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

70.5

55.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

54.2

2139

15502

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

54.1

825

4502

D16

ICPC

Rectal bleeding

4.6

53.9

194

430

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.1

53.6

115

128

WVA20

NOMESCO Finland

Medicine administration

4.3

53.5

207

493

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.8

52.2

152

265

A02BC01

ATC

omeprazole; systemic

1.6

50.9

1484

9934

K50

ICD-10 Finland

Crohn disease [regional enteritis]

14.3

50.1

UJK02

NOMESCO Finland

ERCP

4.4

49.7

186

429

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

49.6

789

4362

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.0

48.4

202

517

N02AX02

ATC

tramadol; systemic, rectal

1.5

48.0

2315

17445

1490

FHL

Sigmoideoscopy (fiberscope)

24.5

48.0

J01MA12

ATC

levofloxacin; systemic

1.8

47.2

995

6046

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

11.7

46.5

A02BC03

ATC

lansoprazole; oral

1.6

46.1

1514

10410

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

236.6

46.0

L04AA01

ATC

[U] ciclosporin; systemic

5.1

45.8

150

301

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

19.3

43.9

UJG02

NOMESCO Finland

Proctoscopy

4.0

43.3

181

464

UJF34

NOMESCO Finland

Left colonoscopy

9.0

42.9

103

L04AA33

ATC

vedolizumab; parenteral

94.7

42.8

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

115.8

42.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

42.4

2191

16634

A02BC05

ATC

esomeprazole; systemic

1.5

41.8

2184

16608

B01AB05

ATC

enoxaparin; parenteral

1.5

41.6

1516

10644

R50.9

ICD-10 Finland

Fever, unspecified

1.8

41.3

827

4929

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

41.2

1198

7946

JF1BD

NOMESCO Finland

Very extensive small bowel CT

9.3

40.7

TJF80

NOMESCO Finland

Ostomy education

6.7

40.6

106

161

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

39.0

396

1812

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

39.0

733

4274

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

7.7

36.7

115

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

36.6

432

2114

JFF13

NOMESCO Finland

Terminal enterostomy

17.4

36.2

K60.3

ICD-10 Finland

Anal fistula

3.6

36.1

168

473

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.7

36.1

163

448

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

36.0

567

3106

6410

FHL

Panprococolectomy and ileostomy

359.3

36.0

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

359.3

36.0

5551A

ICD-9 Finland

Regional enteritis, Large intestine

186.0

35.8

WX402

NOMESCO Finland

General anaesthesia

1.6

35.7

971

6305

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

14.4

35.4

Z93

ICD-10 Finland

Artificial opening status

14.4

35.4

D18

ICPC

Change in faeces/bowel movements

3.7

35.0

157

429

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

34.8

1509

10949

JF2AB

NOMESCO Finland

Colongraphy with X-ray

15.0

34.8

JHA00

NOMESCO Finland

Anal or perianal incision

4.0

33.7

140

358

K56.7

ICD-10 Finland

Ileus, unspecified

4.8

33.6

115

244

D06BX01

ATC

metronidazole; topical

1.9

33.5

569

3198

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

50.3

33.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

33.2

333

1512

A06AC51

ATC

ispaghula, combinations; systemic

2.5

33.1

279

1161

D11

ICPC

Diarrhoea

1.7

32.7

717

4377

M45

ICD-10 Finland

Ankylosing spondylitis

3.1

32.7

182

589

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

10.1

32.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

32.4

350

1646

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

31.6

2600

21188

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.7

31.1

109

237

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

30.7

951

6367

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

30.5

251

1034

J01DB01

ATC

cefalexin; oral

1.4

30.2

5049

46029

K61.0

ICD-10 Finland

Anal abscess

3.3

29.9

153

466

UJF30

SPAT

8.4

29.8

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

25.8

29.6

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

17.8

29.6

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

12.8

29.2

1380

FHL

Colonoscopy, left side

31.8

29.0

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

15.8

28.9

C05AA01

ATC

hydrocortisone; rectal, topical

2.3

28.8

278

1242

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

80.5

28.7

UJF02

NOMESCO Finland

Peroral enteroscopy

7.9

28.3

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.4

28.1

244

1033

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.2

28.0

171

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

282.7

27.8

E0000UV

ATC

1.4

27.7

2209

17794

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

27.6

284

1307

6525

FHL

Enterostomy occlusion

28.6

27.5

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.4

27.5

136

404

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.5

27.5

218

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

27.1

1107

7874

D07AC01

ATC

betamethasone; topical

1.4

26.9

1793

14003

SPAT1262

SPAT

Handing over of treatment supplies

1.5

26.8

889

6032

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

26.8

168

591

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

272.1

26.7

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.4

26.7

226

944

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

3.9

26.5

111

288

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

26.5

218

898

JHD00

NOMESCO Finland

Anal dilatation

5.8

25.8

129

M05BA04

ATC

alendronic acid; oral

2.1

25.8

291

1395

UJD02

NOMESCO Finland

Gastroscopy

2.3

25.6

240

1057

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

14.6

25.1

ZXC86

NOMESCO Finland

Use of endoscopic device

6.9

24.9

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

24.7

379

2052

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

24.4

334

1737

K76.9

ICD-10 Finland

Liver disease, unspecified

3.7

23.2

104

287

JAH00

NOMESCO Finland

Laparotomy

2.7

23.0

160

601

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

11.1

22.8

WW200

NOMESCO Finland

Immunization

2.5

22.8

185

758

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

22.7

265

1291

6408

FHL

Colectomy and ileostomy

230.7

22.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

22.5

542

3383

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

8.4

22.3

Z94.4

ICD-10 Finland

Liver transplant status

8.5

22.0

JF1AD

NOMESCO Finland

Small bowel CT

6.8

21.5

SPAT1263

SPAT

Sampling

1.3

21.3

2315

19327

J01FA10

ATC

azithromycin; systemic

1.3

21.3

3502

30890

R01AD08

ATC

fluticasone; nasal

1.4

21.3

1576

12434

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

21.1

2119

17486

JFB00

NOMESCO Finland

Partial resection of small intestine

3.6

21.1

269

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.2

21.1

125

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.6

20.7

158

JJC00

NOMESCO Finland

Allogenic transplantation of liver

11.2

20.4

E86

ICD-10 Finland

Volume depletion

3.1

20.3

112

364

A07AA02

ATC

nystatin; oral

2.0

20.0

277

1447

K74.3

ICD-10 Finland

Primary biliary cirrhosis

6.5

20.0

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.6

19.6

149

K56.0

ICD-10 Finland

Paralytic ileus

4.5

19.6

158

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

9.8

19.5

UJH02

NOMESCO Finland

Anoscopy

2.1

19.5

223

1079

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

13.8

19.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

19.3

151

610

Y0599

ICD-8 Finland

Investigation of digestive system

3.4

19.2

280

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

8.0

19.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

19.1

414

2509

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

18.8

5078

53893

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.2

18.7

D99

ICPC

Disease digestive system other

4.0

18.7

185

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

18.4

112

388

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.4

18.4

150

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

18.3

437

2722

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

18.1

212

1037

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

17.5

458

2918

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.4

17.1

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

9.8

17.1

UJF32

SPAT

3.1

16.9

298

5604

FHL

Vascular preparation or cannulation in the operating room

8.6

16.9

Z43.2

ICD-10 Finland

Attention to ileostomy

10.0

16.9

J05AB01

ATC

aciclovir; systemic

1.4

16.8

1019

7748

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.7

1757

14488

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

16.7

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

16.6

373

2282

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

20.1

16.4

K83.1

ICD-10 Finland

Obstruction of bile duct

3.9

16.3

169

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

16.3

429

2743

D07AD01

ATC

clobetasol; topical

1.4

16.2

732

5277

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

11.6

16.0

D07AC13

ATC

mometasone; topical

1.3

16.0

1462

11821

J02AC01

ATC

fluconazole; systemic

1.3

15.9

2022

17062

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

7.7

15.8

A02BA02

ATC

ranitidine; systemic

1.4

15.7

821

6075

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.4

15.6

217

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.9

15.4

163

D29

ICPC

Digestive symptom/complaint other

2.7

15.4

102

376

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

15.4

219

D01

ICPC

Abdominal pain/cramps general

1.5

15.4

544

3727

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.5

15.1

118

478

SPAT1131

SPAT

Colonoscopy

2.2

15.1

152

699

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

15.1

135

585

1470

FHL

Rectoscopy

5.3

15.0

K62.4

ICD-10 Finland

Stenosis of anus and rectum

9.4

14.9

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

14.9

343

2117

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.8

1665

13807

SPAT1255

SPAT

Intravenous administration of medicine

1.7

14.8

305

1821

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

5.1

14.8

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

16.5

14.7

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

25.1

14.7

L88

ICD-10 Finland

Pyoderma gangrenosum

9.1

14.6

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

14.6

433

2849

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

7.5

14.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.4

2261

19503

J01AA02

ATC

doxycycline; systemic

1.2

14.2

4296

39701

J05AB11

ATC

valaciclovir; oral

1.4

14.0

609

4351

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.8

14.0

332

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

13.9

160

778

WZC30

NOMESCO Finland

Teaching

1.4

13.9

606

4333

JHD20

NOMESCO Finland

Incision of fistula-in-ano

3.1

13.9

249

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.6

13.8

384

B80

ICPC

Iron deficiency anaemia

2.5

13.8

105

419

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

13.7

336

2105

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.2

13.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

13.7

216

1186

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

13.6

268

1580

A98

ICPC

Health maint/preventive medicine

1.5

13.6

6236

60591

E000001

ATC

1.3

13.6

1070

8445

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.6

318

1970

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

13.6

418

2775

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

13.6

406

2680

JFH31

NOMESCO Finland

Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

13.5

6522

FHL

Ileostomy

140.3

13.4

L01BB01

ATC

9.7

13.2

R01AD09

ATC

mometasone; nasal

1.2

12.9

2487

21853

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

6.4

12.9

JFA76

NOMESCO Finland

Closure of fistula of small intestine

50.1

12.8

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

6.1

12.8

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

12.8

308

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

11.5

12.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

12.8

316

1987

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.5

12.7

167

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

70.0

12.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

12.6

180

956

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.5

3486

31739

J01CA04

ATC

amoxicillin; systemic

1.2

12.5

4950

46688

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.5

12.3

379

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

12.2

1699

14394

ICD-10 Finland

2.2

12.2

121

553

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.6

12.0

A07AA11

ATC

rifaximin; oral

8.2

12.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

11.9

187

1026

Z90.4

ICD-10 Finland

Acquired absence of other parts of digestive tract

46.7

11.9

J01FA06

ATC

roxithromycin; oral

1.2

11.8

2029

17581

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

11.7

252

1528

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

11.7

1383

11492

JJ5AT

NOMESCO Finland

12.5

11.6

6437

FHL

Rectum resection and sphincter-sparing through-anastomosis

+∞

11.5

K90.0

ICD-10 Finland

Coeliac disease

2.0

11.4

140

703

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

11.4

414

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

11.4

1412

11798

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

11.4

571

4190

S18

ICPC

Laceration/cut

1.2

11.3

1954

16916

RD210

NOMESCO Finland

2.3

11.3

107

479

SPAT1153

SPAT

Removal of sutures

1.2

11.3

1408

11768

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.8

11.1

254

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.4

11.0

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

11.0

154

815

B02.9

ICD-10 Finland

Zoster without complication

1.7

11.0

215

1268

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

11.0

623

4667

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

10.9

913

7251

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

43.4

10.9

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

10.9

149

782

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

10.9

1557

13203

A03BA03

ATC

hyoscyamine; oral

3.8

10.8

116

L52

ICD-10 Finland

Erythema nodosum

3.7

10.8

121

D07XC01

ATC

betamethasone, combinations; topical

1.4

10.8

532

3891

J01FA09

ATC

clarithromycin; systemic

1.2

10.8

1631

13916

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

6.1

10.7

JD1AB

NOMESCO Finland

Gastro-duodenography with X-ray

17.8

10.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.7

2038

17797

L04AB02

ATC

infliximab; parenteral

60.1

10.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

10.6

352

2379

WX110

NOMESCO Finland

Local anesthesy

1.2

10.5

4050

37694

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021589) Normoblasts [#/volume] in Blood

4581

26292

2.93

307.65

16.8

8.8

e9/l

0.0

2.13

4094

21535

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

337

190

18.53

307.65

2.4

1.9

mg/l

9.4

9.2

0.13

285

152

(40760892) CBC W Ordered Manual Differential panel - Blood

3028

14013

2.96

307.65

10.0

4.2

—

(3018010) Neutrophils/100 leukocytes in Blood

5575

28311

4.87

307.65

13.1

5.8

57.0

56.7

1.43

5396

26678

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1637

1825

11.22

307.65

1.7

1.6

iu/ml

3.8

4.2

0.03

352

376

(3006315) Basophils [#/volume] in Blood

5944

29471

6.06

307.65

13.7

5.9

e9/l

0.0

4.91

5560

25705

(3019069) Monocytes/100 leukocytes in Blood

5570

27707

5.02

307.65

14.0

6.3

8.7

8.5

7.47

5393

26132

(3002179) Metamyelocytes/100 leukocytes in Blood

1607

4256

4.54

307.65

5.7

4.0

0.3

0.6

6.16

341

916

(3025159) Blasts/100 leukocytes in Blood

1556

4200

4.42

307.65

6.3

4.3

0.0

0.2

1.09

363

975

(42870588) Differential panel, method unspecified - Blood

4680

19444

4.79

307.65

12.0

5.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

814

157

58.09

307.65

3.3

3.6

mg/l

8.6

7.2

2.09

680

114

(3002030) Lymphocytes/100 leukocytes in Blood

5609

28743

4.87

307.65

13.8

6.0

28.7

28.8

0.21

5424

26981

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3465

13212

4.04

307.65

3.9

2.1

mg/l

2.8

0.07

3159

11373

(3013707) Erythrocyte sedimentation rate by Westergren method

6418

42881

4.62

307.65

7.4

3.7

mm/h

11.4

10.3

8.91

6123

40146

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2438

3433

10.08

307.65

2.2

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

706

151

51.55

307.65

2.8

3.0

au/ml

122.2

156.3

0.28

101

(3017181) Myelocytes/100 leukocytes in Blood

1686

4639

4.41

307.65

6.1

4.2

0.7

0.9

4.19

452

1262

(3021440) Promyelocytes/100 leukocytes in Blood

1623

4425

4.41

307.65

6.2

4.2

0.1

0.2

2.57

423

1172

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

315

173.08

307.65

3.2

2.8

—

(3006504) Eosinophils/100 leukocytes in Blood

5545

27550

4.98

307.65

13.7

6.0

2.8

2.9

0.25

5364

25807

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

839

1226

7.59

307.65

3.3

6.2

iu/ml

838.0

792.9

0.06

173

(3007566) Smooth muscle Ab [Titer] in Serum

865

1665

5.75

307.65

1.8

1.2

titre

66.6

143.2

1.35

154

(3019198) Lymphocytes [#/volume] in Blood

5968

30415

5.87

307.65

13.7

5.9

e9/l

1.9

2.0

8.14

5614

27096

(3022145) Colonoscopy Study observation

4764

5662

21.62

307.65

2.2

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6141

33779

5.69

307.65

15.4

9.1

e9/l

3.9

4.1

9.77

5744

29587

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6962

43492

10.37

307.65

17.7

7.0

u/l

75.1

76.2

1.51

6859

41199

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5253

22695

5.47

307.65

3.7

2.2

nmol/l

74.7

74.5

0.22

5089

20851

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

430

516

8.78

307.65

2.1

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3634

20097

2.58

307.65

4.9

3.2

u/l

30.1

34.4

3.86

3338

19163

(3024561) Albumin [Mass/volume] in Serum or Plasma

5867

22525

8.59

307.65

9.6

4.9

g/l

37.0

36.2

28.24

5696

21013

(3048689) Calprotectin [Mass/mass] in Stool

5974

7291

37.53

307.65

7.6

1.8

ug/g

238.4

106.9

75.53

5733

5693

(3001604) Monocytes [#/volume] in Blood

5931

29367

6.03

307.65

13.7

5.9

e9/l

0.6

3.23

5541

25628

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

717

1178

6.63

307.65

5.0

3.6

56.9

57.0

0.08

717

1178

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

325

178.82

307.65

3.1

2.8

mg/l

23.2

16.2

2.14

308

(3034770) Mitochondria Ab [Titer] in Serum

850

1641

5.72

307.65

1.7

1.2

titre

462.9

945.6

—

(3022096) Basophils/100 leukocytes in Blood

5482

26687

5.01

307.65

13.8

6.1

0.7

22.37

5295

25040

(3017143) Hepatitis C virus Ab [Presence] in Serum

2166

8793

3.06

307.65

1.5

1.7

—

(3013115) Eosinophils [#/volume] in Blood

6015

30527

6.07

307.65

13.9

6.2

e9/l

0.2

2.06

5637

27091

(3025941) Bacteria identified in Stool by Culture

1302

3570

4.21

307.65

1.5

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2503

12231

2.58

295.86

1.6

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4288

26828

2.41

291.61

3.9

2.8

ug/l

97.0

115.7

5.19

4098

25213

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

242

157

15.90

280.37

2.0

1.6

au/ml

86.4

167.9

0.75

(3028026) IgM [Mass/volume] in Serum or Plasma

1098

3515

3.49

279.23

2.0

1.8

g/l

1.2

1.3

0.45

1036

3243

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1714

7125

2.83

277.59

2.7

2.6

22.4

23.8

3.82

1496

6165

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4419

28589

2.34

269.83

7.9

6.1

umol/l

10.8

11.2

0.98

4245

27115

(3005719) IgG [Mass/volume] in Serum or Plasma

1251

4573

3.09

254.16

2.7

2.6

g/l

11.7

10.5

22.88

1173

4194

(3022948) Iron [Moles/volume] in Serum or Plasma

1856

8373

2.62

253.13

2.7

2.5

umol/l

13.3

13.8

2.11

1773

7821

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1750

7699

2.66

250.92

2.7

2.5

g/l

2.4

5.46

1667

7174

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

343

460

7.77

241.63

1.5

1.2

titre

292.6

212.5

0.82

136

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1288

4927

2.95

240.44

3.6

2.4

g/l

0.2

7.56

1223

4610

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

342

460

7.74

240.30

1.5

1.2

titre

383.2

178.2

0.63

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

533

1133

4.99

235.36

1.6

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

155

25.93

223.43

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7183

61221

6.04

219.15

25.4

12.2

mg/l

15.3

22.7

122.01

6412

47573

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2979

17524

2.17

214.02

4.0

2.6

u/l

59.8

56.7

2.05

2814

16271

(3037522) Nuclear Ab [Titer] in Serum

1744

8419

2.40

199.87

1.7

1.3

titre

539.8

521.7

0.15

481

1569

(3024980) IgG subclass 4 [Mass/volume] in Serum

461

997

4.86

198.92

2.3

1.6

g/l

0.8

0.10

381

755

(40768804) Tissue Pathology biopsy report

3575

22998

2.07

198.20

2.5

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

547

1405

4.12

189.37

1.3

u/ml

270.2

257.1

0.40

316

904

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

565

1494

4.01

187.93

1.2

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

552

1436

4.07

187.78

1.9

1.4

iu/ml

5.0

15.3

1.64

(40758558) Short blood count panel - Blood

2535

14605

2.12

186.40

10.4

7.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

287

448

6.62

175.63

2.4

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

615

1876

3.48

165.35

2.0

1.6

titre

379.3

423.6

0.14

(3003327) Ova and parasites identified in Stool by Light microscopy

670

2182

3.28

162.17

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

691

2333

3.16

157.35

1.8

1.6

u/ml

5.7

15.9

2.00

(3007164) IgA [Mass/volume] in Serum or Plasma

2180

12544

2.04

155.41

1.8

1.4

g/l

2.5

2.3

3.07

1579

7988

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

329

664

5.14

153.53

1.7

1.4

—

(3032080) INR in Blood by Coagulation assay

3140

20570

1.91

152.61

8.5

7.9

inr

1.1

1.2

7.54

1127

6245

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

325

653

5.16

152.44

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

404

972

4.34

152.06

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

324

652

5.15

151.69

1.7

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

480

1336

3.77

147.78

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

411

1037

4.14

145.16

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

316

647

5.06

144.98

1.7

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

550

1697

3.42

144.81

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

344

758

4.71

144.59

1.4

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

315

645

5.06

144.50

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

315

649

5.02

143.46

1.7

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

546

1688

3.41

143.27

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

543

1676

3.42

142.84

1.3

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2478

15371

1.92

139.09

1.8

2.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6619

56689

2.52

138.14

19.9

11.0

ml/min/173m2

90.1

87.9

14.61

5797

46628

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

521

1611

3.40

136.54

5.6

3.5

u/ml

51.4

3329.4

1.19

475

1378

(3048929) Epstein Barr virus Ab [Presence] in Serum

681

2479

2.92

135.23

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3640

25817

1.80

130.35

6.9

6.8

mmol/l

1.2

1.45

3048

21857

(40768441) Liver Pathology biopsy report

230

403

5.86

125.17

1.7

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

653

2447

2.83

122.52

1.2

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

259

518

5.14

121.96

1.3

1.2

u/l

57.6

62.4

0.43

176

350

(3002385) Erythrocyte distribution width [Ratio]

6161

52120

2.06

117.93

26.8

14.8

13.7

13.5

13.69

6127

51050

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7193

65276

4.08

117.25

22.4

9.2

u/l

27.3

28.1

2.72

7134

63303

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3309

23353

1.75

115.87

6.1

6.2

mmol/l

1.2

2.88

3057

21366

(40761536) Microorganisms panel - Urine sediment

1035

5016

2.24

111.48

4.2

3.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

22.12

110.00

1.1

u/ml

26.0

45.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

22.12

110.00

1.1

u/ml

20.1

26.9

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

102

13.78

109.97

2.4

1.8

mg/l

2.1

1.5

2.72

(3037467) Urinalysis macro (dipstick) panel - Urine

5001

39978

1.77

109.22

4.6

3.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1818

10919

1.88

107.74

2.4

1.6

pmol/l

36893636.4

30893683.5

0.17

1648

9303

(3023368) Bacteria identified in Blood by Culture

2181

13869

1.81

107.43

4.7

4.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1077

5381

2.17

107.24

3.5

2.5

u/l

40.3

46.3

0.29

966

4653

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

148

192

7.84

106.93

1.8

u/ml

4792.1

18235.1

0.39

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1240

6570

2.06

105.72

4.3

2.8

umol/l

6.6

7.6

1.33

1097

5699

(3018418) pH of Serum or Plasma

2333

15216

1.78

105.00

4.1

4.2

7.4

0.24

482

3022

(3010375) cycloSPORINE [Mass/volume] in Blood

179

292

6.26

104.73

17.0

26.2

ug/l

133.6

117.0

2.01

163

230

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

308

833

3.81

98.40

1.1

g/l

1.5

0.74

288

749

(3019309) Folate [Moles/volume] in Red Blood Cells

1486

8695

1.89

93.83

2.1

1.7

nmol/l

1171.7

1162.2

0.13

994

6751

(3033658) Prothrombin time (PT) actual/Normal

2202

14544

1.73

92.40

6.0

3.9

94.0

92.1

3.28

2144

14186

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

168

299

5.73

89.88

1.7

1.5

u/l

5.0

5.8

0.25

145

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

167

305

5.58

86.92

1.4

1.2

u/l

79.4

89.7

0.62

137

262

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

162

294

5.61

84.89

1.4

1.2

u/l

22.1

21.4

0.04

134

248

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1069

5789

1.99

84.22

1.3

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2862

20742

1.62

81.51

2.0

1.9

pmol/l

96.4

96.5

0.04

1710

11215

(3019550) Sodium [Moles/volume] in Serum or Plasma

6726

60658

2.14

80.82

18.7

13.5

mmol/l

139.4

139.7

13.15

6582

59094

(3023103) Potassium [Moles/volume] in Serum or Plasma

6744

60888

2.15

80.69

18.8

13.6

mmol/l

3.9

4.0

38.72

6589

59198

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2121

14294

1.68

80.41

1.3

u/ml

1.5

1.7

0.29

539

4018

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

889

4626

2.05

77.94

5.1

4.1

ug/l

9.1

31.8

2.01

687

3663

(3004716) Salmonella sp identified in Stool by Organism specific culture

715

3473

2.17

75.03

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

276

844

3.36

73.11

3.1

3.3

0.8

1.4

3.66

207

655

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

182

417

4.45

72.68

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

181

421

4.38

70.91

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4079

32819

1.54

69.35

5.3

4.7

mmol/l

6.6

0.32

3828

30401

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

416

1646

2.62

69.33

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

1255

7580

1.79

69.25

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

182

433

4.28

69.25

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

190

467

4.15

69.24

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

182

437

4.24

68.42

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

181

6.32

67.33

1.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

3660

28926

1.52

66.46

3.8

3.3

estimate

0.0

0.51

1086

5312

(3029937) Albumin [Presence] in Urine by Test strip

2152

15141

1.59

66.01

4.2

3.6

estimate

0.0

0.04

1086

5287

(3035350) Ketones [Presence] in Urine by Test strip

3623

28610

1.52

65.78

3.8

3.3

estimate

0.0

1.28

1083

5330

(3017732) Neutrophils [#/volume] in Blood

782

4124

2.00

65.46

2.9

2.7

e9/l

4.2

0.00

570

3383

(3021601) Nitrite [Presence] in Urine by Test strip

3622

28645

1.52

65.00

4.9

4.4

estimate

0.0

0.80

1110

5520

(40761511) CBC panel - Blood by Automated count

6947

64485

2.17

60.64

19.1

11.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

277

951

2.99

60.36

5.4

3.6

u/ml

119.6

615.8

1.12

253

883

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

355

1440

2.54

56.08

1.3

1.5

u/ml

14.3

21.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

946

5567

1.80

56.04

2.3

2.2

nmol/l

328.5

371.3

10.71

878

5117

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

7.69

55.12

1.4

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

354

1446

2.52

55.10

1.3

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2229

16349

1.52

54.57

3.6

2.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

331

1323

2.57

53.90

1.3

1.5

u/ml

108.7

111.1

0.17

253

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2900

22483

1.48

53.88

4.0

3.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

143

352

4.12

52.05

1.1

miu/ml

1596.0

1452.3

0.72

143

352

(3041672) Baker's yeast Ab [Presence] in Serum

13.91

51.01

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

174

505

3.50

50.02

1.1

mg/l

282.4

284.4

0.12

156

460

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

263

1009

2.67

46.52

2.7

3.0

u/ml

960.0

1149.4

0.12

(3052851) Hemolysis interference index of Serum or Plasma

365

1636

2.29

46.13

3.3

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1607

11337

1.53

45.79

1.6

1.5

nmol/l

20.1

20.2

0.08

1440

9915

(3017354) Segmented neutrophils/100 leukocytes in Blood

169

511

3.36

45.60

3.0

3.3

59.1

56.8

0.59

104

324

(3027945) Reticulocytes/100 erythrocytes in Blood

890

5449

1.72

45.34

3.8

2.7

1.8

1.29

810

4862

(3007461) Platelets [#/volume] in Blood

7246

69414

2.69

42.70

34.4

17.8

e9/l

271.9

253.3

91.67

7197

67843

(3008898) HLA-B27 [Presence]

488

2525

2.00

42.54

1.1

—

(3035941) MCH [Entitic mass]

7247

69477

2.67

41.73

34.2

17.7

30.4

30.2

12.59

7221

68663

(3024731) MCV [Entitic volume]

7247

69481

2.67

41.65

34.2

17.7

91.3

90.3

60.02

7221

68670

(3026361) Erythrocytes [#/volume] in Blood

7247

69493

2.66

41.41

34.4

17.8

e12/l

4.5

4.6

28.60

7183

67785

(4035726)

755

4523

1.74

41.38

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1181

7936

1.58

41.35

2.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1007

6515

1.63

41.29

8.8

7.5

mmol/l

104.8

104.5

1.42

992

6370

(3010813) Leukocytes [#/volume] in Blood

7248

69516

2.66

41.23

34.5

17.8

e9/l

6.8

6.7

3.84

7185

67777

(3000963) Hemoglobin [Mass/volume] in Blood

7247

69516

2.65

40.95

34.6

17.9

g/l

136.3

137.9

19.33

7220

68695

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

213

4.60

40.94

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

213

4.60

40.94

1.5

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4337

37351

1.39

39.62

4.3

3.9

e6/l

1281.6

1265.4

0.00

469

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

254

1044

2.48

38.99

1.2

1.3

titre

146.7

222.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

109

276

3.99

38.26

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

663

3920

1.76

37.93

2.9

2.7

e9/l

74.5

70.8

1.36

510

2913

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

100

244

4.14

36.91

1.2

1.1

u/l

12.9

24.5

3.12

193

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

284

3.88

36.79

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

6.53

36.53

2.2

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

2148

16634

1.41

36.36

3.3

3.1

e6/l

79.9

90.8

0.16

1751

12707

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

345

1666

2.12

36.22

4.0

4.1

mg/l

1.3

1.4

1.27

317

1558

(3008757) Leukocyte morphology finding [Identifier] in Blood

157

523

3.05

36.13

3.5

3.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

245

4.08

35.87

1.2

1.1

u/l

65.2

90.3

2.47

201

(3030467) Casts [#/volume] in Urine by Automated count

1980

15212

1.41

34.77

3.2

3.0

e6/l

0.4

0.3

0.72

1571

11378

(3016650) Hepatitis A virus Ab [Presence] in Serum

253

1122

2.30

32.78

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

2264

17932

1.38

32.75

2.8

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1019

6955

1.54

32.65

6.2

6.6

mmol/l

1.0

1.52

965

6549

(3020961) Endomysium IgA Ab [Titer] in Serum

540

3139

1.78

32.62

1.1

titre

48.6

184.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3260

27335

1.34

32.54

4.7

3.9

—

(36304419) Bacteria [Presence] in Urine

1941

15004

1.40

32.48

3.1

2.9

—

(3018095) Leukocytes [#/volume] in Urine

2453

19765

1.36

31.57

3.8

3.5

e6/l

74.7

77.6

0.05

1859

13775

(3000850) Epithelial cells [#/volume] in Urine

1538

11491

1.43

31.07

2.7

2.5

e6/l

5.9

5.7

0.16

1388

10085

(3009871) Measles virus Ab [Titer] in Serum

224

3.96

30.73

1.7

—

(3026782) Osmolality of Urine

1439

10669

1.43

30.22

2.8

2.7

mosm/kgh2o

556.3

556.7

0.02

1278

9130

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

243

3.78

29.73

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

242

1108

2.22

29.07

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

196

4.06

28.59

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

6.59

25.07

1.8

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

645

4203

1.59

25.04

3.9

mmol/l

1.2

0.42

575

3702

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1183

8737

1.42

24.87

4.3

3.7

mmol/l

0.8

5.43

1097

8219

(3020779) Urea [Moles/volume] in Serum or Plasma

709

4732

1.55

24.78

9.1

8.6

mmol/l

8.5

9.1

1.42

674

4542

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

143

4.36

24.73

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1662

13006

1.36

24.61

1.9

1.8

mg/l

1.1

0.51

1284

9681

(3015377) Calcium [Moles/volume] in Serum or Plasma

2143

17449

1.32

24.15

3.3

mmol/l

2.3

0.88

1914

15565

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1122

8257

1.42

23.99

2.0

1.8

—

(4062490)

160

668

2.43

23.85

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

476

2.70

23.67

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

159

665

2.42

23.62

1.2

1.4

g/l

0.4

0.02

467

(3028192) IgG subclass 2 [Mass/volume] in Serum

159

666

2.42

23.54

1.2

1.4

g/l

3.0

0.05

471

(3027135) IgG subclass 1 [Mass/volume] in Serum

159

666

2.42

23.54

1.2

1.4

g/l

8.2

6.6

4.52

467

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1287

9727

1.39

23.54

1.3

u/ml

6.7

10.6

1.81

453

4014

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

783

5402

1.50

23.40

3.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1713

13618

1.34

22.53

2.8

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

6235

58733

1.38

22.25

22.5

12.9

40.2

40.7

3.79

4703

46266

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4827

43905

1.28

22.03

4.6

3.0

u/l

53.7

44.7

8.91

4581

41676

(3052592) Norovirus Ag [Presence] in Stool

5.34

21.32

1.9

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

282

1549

1.85

20.51

1.6

1.4

ug/g

280.2

286.8

0.21

172

870

(3019225) pH of Specimen

706

4901

1.49

20.36

3.8

4.1

—

(3026008) Bacteria identified in Urine by Culture

1791

14532

1.31

19.97

2.9

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2344

19708

1.28

19.79

3.4

3.2

ng/l

46.8

54.8

0.27

1431

11739

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1321

10317

1.34

19.20

1.3

iu/ml

23.3

31.6

1.16

404

3176

(3002032) Base excess in Venous blood by calculation

681

4765

1.47

18.83

5.0

4.2

mmol/l

1.7

1.8

0.18

538

3865

(3013005) Retinol [Moles/volume] in Serum or Plasma

286

2.96

18.80

2.0

1.8

umol/l

2.1

1.9

0.68

270

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

233

3.15

18.26

3.7

2.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

919

6881

1.38

17.37

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

671

4779

1.44

16.86

5.1

4.2

kpa

5.8

5.9

0.11

644

4631

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

305

1830

1.70

16.43

1.1

u/ml

2.6

5.8

1.41

272

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

786

5830

1.39

15.65

3.9

4.5

u/l

224.1

238.4

3.29

745

5528

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

352

2220

1.61

15.63

1.9

1.8

g/l

1.4

1.5

0.51

309

1916

(3022217) INR in Platelet poor plasma by Coagulation assay

816

6095

1.38

15.57

20.5

20.3

inr

1.2

0.17

167

938

(3015171) Extractable nuclear Ab [Units/volume] in Serum

370

2367

1.59

15.48

1.3

1.2

u/ml

0.3

1.1

2.74

208

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1163

9189

1.31

15.26

2.8

2.6

e6/l

0.9

1.0

0.25

693

5137

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1095

8607

1.32

14.88

3.0

2.8

e6/l

2.3

2.4

0.07

626

4572

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

748

5599

1.37

14.04

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

755

5669

1.37

13.90

1.9

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

303

1900

1.62

13.80

1.5

1.7

g/l

1.2

0.03

285

1804

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

376

2.41

13.59

3.1

2.6

92.4

95.8

0.46

353

(3000494) Fungus identified in Specimen by Culture

887

6855

1.33

13.50

1.6

1.5

—

(3000991) Gas panel - Venous blood

610

4451

1.40

13.34

9.6

9.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

293

1839

1.62

13.30

1.5

1.7

g/l

0.2

1.65

274

1744

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

379

2527

1.53

13.23

1.8

2.0

u/l

38.5

39.4

0.37

332

2294

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

295

1869

1.60

12.90

1.9

—

(36660697) Celiac disease serology panel - Serum

686

5133

1.37

12.88

1.2

—

(3028433) Virus identified in Specimen by Culture

189

2.98

12.85

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4946

46220

1.21

12.82

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

389

2629

1.51

12.75

5.2

4.5

mmol/l

24.0

24.1

0.31

361

2370

(3020717) Zinc [Moles/volume] in Serum or Plasma

338

2.41

12.30

1.6

1.5

umol/l

26.2

25.2

0.11

324

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

220

1314

1.69

12.15

1.8

1.6

—

(40768443) Skin Pathology biopsy report

353

2375

1.51

11.84

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

473

3376

1.43

11.72

7.9

7.8

mmol/l

24.5

24.7

0.71

466

3357

(40767503) Oxygen content in Capillary blood by calculation

192

1121

1.73

11.53

2.3

2.5

16.9

16.8

0.09

541

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

119

604

1.99

11.15

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

497

3625

1.40

10.89

4.0

4.3

ng/l

87.8

89.8

0.16

444

3216

(3034274) Bile acid [Moles/volume] in Serum --fasting

178

1036

1.74

10.84

2.4

2.3

umol/l

13.3

6.0

2.24

138

755

(3002173) Hemoglobin [Mass/volume] in Arterial blood

630

4800

1.34

10.50

8.3

8.9

g/l

121.5

123.5

1.66

607

4627

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

595

4502

1.35

10.38

2.9

2.5

ml/min/173m2

71.9

71.7

0.03

251

1694

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

187

2.74

10.15

2.0

3.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

288

1922

1.52

10.08

2.0

ug/l

7.4

2.2

0.51

256

1725

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

196

1196

1.66

10.05

1.2

1.3

u/ml

5.2

4.5

0.08

(3004588) Protein electrophoresis panel - Serum or Plasma

430

3108

1.41

9.95

2.4

2.2

—

(3042733) HLA Ab [Presence] in Serum

248

2.47

9.88

2.9

5.0

—

(3016502) Oxygen saturation in Arterial blood

666

5164

1.32

9.82

8.0

8.4

96.6

95.9

3.11

637

4975

(3013512) EKG study

1684

14549

1.20

9.63

3.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

517

3880

1.36

9.52

2.5

2.6

g/l

67.4

66.9

0.88

491

3588

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1633

14089

1.20

9.45

1.7

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

518

3894

1.35

9.44

4.4

3.6

kpa

4.5

4.7

1.95

495

3759

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

231

2.48

9.32

2.9

3.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

243

1594

1.54

9.24

2.6

—

(3012501) Base excess in Blood by calculation

202

1270

1.61

9.23

3.2

4.2

mmol/l

2.4

0.03

130

846

(3013290) Carbon dioxide [Partial pressure] in Blood

202

1271

1.61

9.20

3.3

4.2

kpa

4.9

5.0

0.80

196

1252

(3011397) Hemoglobin [Presence] in Urine by Test strip

1515

13015

1.21

9.14

3.5

3.3

—

(3027315) Oxygen [Partial pressure] in Blood

202

1277

1.60

9.03

3.3

4.2

kpa

8.9

8.8

0.23

196

1257

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

250

1664

1.52

8.91

1.2

1.3

u/ml

20.3

32.8

0.36

101

(3051651) Icteric interference index of Serum or Plasma

345

2.16

8.79

4.6

3.6

—

(3002256) Pathology report gross observation

887

7245

1.25

8.66

1.2

—

(1616796) Gas panel - Central venous blood

191

1204

1.60

8.66

3.3

3.7

—

(3051611) Lipemic interference index of Serum or Plasma

517

1.93

8.65

4.4

3.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

243

1622

1.51

8.56

3.7

3.6

u/ml

0.3

0.02

138

919

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

202

1296

1.57

8.51

1.9

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

165

1008

1.65

8.49

3.0

3.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

228

1505

1.53

8.46

1.2

1.3

u/ml

8.0

5.2

0.32

140

(3010421) pH of Blood

224

1475

1.53

8.41

3.2

4.2

7.4

0.13

196

1252

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

269

1842

1.48

8.37

3.1

2.9

g/l

3.4

3.5

1.05

250

1750

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1059

8854

1.23

8.34

3.1

2.9

mmol/l

2.4

1.32

922

7740

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

373

2.08

8.31

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

439

3283

1.36

8.29

4.7

3.7

kpa

5.0

5.1

2.71

405

3050

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

117

3.00

8.28

3.3

3.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

162

2.66

8.19

1.4

umol/l

16.7

16.9

0.09

142

(3009343) pH of Capillary blood

433

3238

1.36

8.18

4.7

3.7

7.4

0.41

393

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

229

1525

1.52

8.17

1.2

1.3

u/ml

12.5

9.6

0.32

228

(3003338) MCHC [Mass/volume]

5722

54928

1.18

8.10

27.5

15.2

g/l

332.3

333.7

24.44

5705

54538

(3014111) Lactate [Moles/volume] in Serum or Plasma

590

4623

1.30

8.06

8.0

7.6

mmol/l

1.3

1.4

0.12

568

4443

(3003396) Base excess in Arterial blood by calculation

718

5770

1.27

8.04

7.7

8.0

mmol/l

0.7

0.9

0.55

563

4487

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

469

3563

1.34

7.99

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

935

1.65

7.89

1.9

1.7

—

(3011412) CD3 cells [#/volume] in Blood

113

635

1.79

7.89

1.8

2.4

e9/l

1.2

0.16

383

(3047181) Lactate [Moles/volume] in Blood

244

1660

1.49

7.87

5.6

6.5

mmol/l

1.3

0.34

217

1457

(3018677) aPTT in Platelet poor plasma by Coagulation assay

982

8203

1.23

7.78

2.6

2.3

30.0

29.7

0.61

949

7965

(3015235) Bicarbonate [Moles/volume] in Capillary blood

196

1279

1.55

7.70

4.6

3.2

mmol/l

23.8

24.5

1.34

168

1113

(3034860) Kappa light chains.free [Mass/volume] in Serum

202

1328

1.54

7.68

3.4

mg/l

47.2

55.2

0.52

159

1068

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

202

1328

1.54

7.68

3.4

mg/l

38.1

57.8

0.99

158

1070

(3023183) Ammonium ion [Moles/volume] in Plasma

187

1210

1.56

7.63

3.7

3.1

umol/l

31.1

35.4

2.54

161

1049

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

305

2178

1.42

7.63

2.2

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

148

906

1.65

7.60

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

1057

1.59

7.50

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

713

5776

1.26

7.46

7.8

8.0

kpa

5.0

5.1

2.28

680

5521

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

126

743

1.71

7.46

1.9

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

414

3122

1.35

7.43

4.8

3.6

mmol/l

1.4

1.5

0.51

304

2307

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

196

1291

1.53

7.40

3.4

ratio

1.4

2.2

0.76

111

(3027801) Oxygen [Partial pressure] in Arterial blood

712

5776

1.26

7.36

7.8

7.9

kpa

13.0

12.7

0.71

680

5523

(3039162) Centromere protein B Ab [Units/volume] in Serum

124

731

1.71

7.36

1.2

1.3

u/ml

5.8

52.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

374

2784

1.36

7.31

11.0

10.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

161

1018

1.59

7.28

1.1

u/ml

2.2

3.5

1.50

535

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

282

2008

1.42

7.19

5.2

5.6

1.7

0.27

265

1872

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.01

7.17

1.0

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

413

3136

1.34

7.09

6.2

7.5

mmol/l

24.2

24.4

0.58

385

2919

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4853

46181

1.15

7.05

3.7

3.8

pmol/l

14.7

14.6

2.95

4477

42618

(3028626) Oxygen [Partial pressure] in Capillary blood

185

1218

1.53

7.02

6.4

3.5

kpa

8.7

8.6

0.39

169

1120

(44816559) Phosphatidylethanol [Mass/volume] in Blood

219

1494

1.48

7.01

1.2

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

253

1779

1.44

6.93

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

119

706

1.70

6.92

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

260

1838

1.43

6.92

2.7

179.8

180.1

0.02

245

1751

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

281

2019

1.41

6.83

2.4

2.5

94.8

92.9

0.67

261

1881

(3007930) Methemoglobin/Hemoglobin.total in Blood

278

1997

1.41

6.77

5.2

5.7

1.0

0.9

1.63

260

1866

(3036071) Salmonella sp Ab [Titer] in Serum

242

2.20

6.73

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1439

12615

1.17

6.67

3.1

3.0

ng/l

1487.6

1207.6

1.11

1194

10562

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

464

1.84

6.59

1.9

2.5

e6/l

466.6

527.4

0.59

384

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

826

1.62

6.52

1.6

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

116

696

1.68

6.50

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.33

6.48

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

266

2.11

6.46

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

266

2.11

6.46

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

266

2.11

6.46

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

266

2.11

6.46

1.6

1.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

315

2337

1.36

6.33

4.4

3.5

mmol/l

24.8

25.2

1.08

302

2259

(3026493) Urate [Moles/volume] in Serum or Plasma

1669

14855

1.16

6.33

2.8

2.5

umol/l

3722.2

3730.2

0.00

1504

13176

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

150

967

1.56

6.30

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

227

1596

1.44

6.26

2.0

2.1

mg/l

10.6

10.7

0.07

209

1502

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

272

1978

1.39

6.19

2.0

1.8

—

(3036489) Thrombin time

311

2313

1.36

6.17

2.3

21.1

21.3

0.45

271

1993

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

454

1.82

6.11

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

454

1.82

6.11

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

454

1.82

6.11

1.6

1.7

—

(40761535) Cells panel - Urine sediment

533

4278

1.26

6.06

3.4

3.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

523

4192

1.27

6.01

1.3

u/ml

269.0

227.2

0.28

489

3893

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5694

54996

1.15

6.01

4.4

4.5

mu/l

1.7

2.1

4.31

5331

51250

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

311

0.22

5.95

3.0

2.3

nmol/l

212.0

151.0

—

267

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

186

1273

1.47

5.93

1.2

u/ml

33.5

42.7

0.28

113

(3044889) 12 lead EKG panel

4201

39814

1.13

5.92

3.4

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1616

1.42

5.87

2.4

2.3

g/l

10.9

10.3

1.06

194

1389

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

1752

1.40

5.84

2.4

2.2

g/l

4.1

3.8

1.16

178

1277

(40761539) Cells [Type] in Urine sediment by Light microscopy

136

2.51

5.84

1.0

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

1753

1.40

5.83

2.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

1753

1.40

5.83

2.4

2.2

g/l

7.1

7.3

0.67

182

1339

(3026389) Candida sp identified in Specimen by Organism specific culture

130

830

1.58

5.73

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

354

2716

1.32

5.72

3.0

2.6

e6/l

0.4

0.2

0.59

344

2627

(3024471) HLA-A [Type]

240

2.09

5.66

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

451

1.78

5.65

1.8

2.5

e9/l

0.2

2.65

382

(3019150) Specific gravity of Urine by Refractometry

1409

12485

1.16

5.61

3.9

3.6

kg/l

1.0

0.33

194

1786

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1783

16069

1.14

5.58

2.2

u/l

225.0

223.4

0.01

1693

15188

(3021901) Oxygen saturation in Capillary blood

137

892

1.55

5.56

4.3

2.8

—

(3037756) Immunofixation for Serum or Plasma

135

878

1.55

5.51

2.1

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

395

3094

1.29

5.49

1.5

—

(3003694) ABO and Rh group [Type] in Blood

2013

18310

1.14

5.46

1.6

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

412

3256

1.28

5.35

9.6

9.9

95.0

94.0

5.04

405

3245

(3006184) Hemoglobin [Mass/volume] in Capillary blood

163

1115

1.47

5.26

2.5

2.3

g/l

130.8

132.4

0.37

133

821

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.85

5.25

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

175

2.24

5.24

1.4

1.5

—

(3039000) Anion gap in Blood

168

1160

1.46

5.17

6.6

7.7

mmol/l

11.5

11.4

0.24

153

1039

(3018572) Chloride [Moles/volume] in Blood

168

1161

1.46

5.15

6.6

7.7

mmol/l

105.1

105.2

0.08

153

1040

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

472

1.72

5.14

1.9

2.6

e6/l

762.6

732.1

0.14

181

(3024932) HLA-DR beta [Type]

236

2.04

5.13

1.0

1.1

—

(3019060) Gas panel - Arterial blood

413

3284

1.27

5.11

4.6

5.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

610

1.63

5.10

2.1

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

158

1083

1.47

5.06

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

158

1083

1.47

5.06

1.5

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

163

1128

1.46

4.97

4.4

3.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

152

1042

1.47

4.88

1.3

u/ml

4.6

4.3

0.10

459

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1664

1.37

4.86

2.5

2.3

g/l

3.1

0.18

181

1313

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1148

10122

1.16

4.84

3.3

3.5

ng/l

675.6

579.4

0.18

775

7073

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

962

8381

1.17

4.74

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

387

3083

1.27

4.74

4.3

3.5

g/l

130.4

131.3

0.33

371

3010

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

404

3241

1.26

4.67

9.7

9.9

0.7

0.23

399

3220

(21494815) CD4 cells/100 lymphocytes in Specimen

573

1.61

4.58

1.8

2.3

51.3

42.9

0.91

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

398

1.74

4.58

2.1

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

147

1015

1.46

4.57

3.5

3.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

747

1.53

4.57

1.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1119

9889

1.15

4.57

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

445

1.69

4.51

2.0

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

270

1.90

4.47

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

153

1073

1.43

4.40

1.3

1.2

u/ml

6.0

3.4

0.99

349

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

402

3248

1.25

4.39

9.5

9.8

1.3

1.4

3.35

396

3228

(4268621)

111

733

1.52

4.32

2.4

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

400

4911

0.80

4.32

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

281

1.86

4.30

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

619

7273

0.84

4.26

1.5

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

117

1711

0.68

4.21

1.7

3.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

235

1783

1.33

4.20

3.2

4.1

mmol/l

1.4

0.15

225

1757

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1499

1.36

4.19

2.7

2.3

g/l

1.0

0.8

0.27

177

1324

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

356

2855

1.26

4.17

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

247

1894

1.31

4.11

1.3

—

(3000330) Specific gravity of Urine by Test strip

309

2444

1.28

4.07

3.8

3.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

631

1.54

4.06

1.6

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

120

822

1.47

3.95

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

217

1646

1.33

3.91

1.6

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

171

2.05

3.89

1.4

1.5

ug/l

11.1

8.3

1.74

171

(3023419) Bacteria identified in Sputum by Culture

616

1.53

3.83

3.3

2.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

172

2.04

3.83

1.3

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.01

3.81

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

200

1.96

3.80

5.3

4.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

169

1242

1.37

3.77

2.7

2.2

g/l

0.0

0.00

158

1152

(40759836) Histone Ab [Presence] in Serum by Immunoblot

469

1.61

3.75

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

167

1226

1.37

3.75

2.7

2.2

g/l

0.0

0.00

156

1150

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

126

881

1.44

3.74

2.6

2.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

470

1.60

3.72

1.3

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1359

1.35

3.67

2.6

2.1

g/l

38.0

0.05

163

1198

(3042631) Mycobacterium sp identified in Specimen

632

1.51

3.63

3.5

2.6

—

(44790048)

665

1.50

3.62

1.6

1.5

—

(44806118)

665

1.50

3.62

1.6

1.5

—

(44790047)

665

1.50

3.62

1.6

1.5

—

(44790049)

665

1.50

3.62

1.6

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

180

1346

1.35

3.61

2.6

2.2

g/l

0.0

0.07

169

1253

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

474

1.59

3.60

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

474

1.59

3.60

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

336

1.70

3.59

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

475

1.58

3.57

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

234

1.84

3.54

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

200

1524

1.32

3.53

3.4

4.4

mmol/l

3.8

3.9

1.30

187

1426

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

469

1.58

3.52

1.3

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.17

3.49

1.4

3.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

527

1.54

3.45

2.8

2.3

—

(3015183) Erythrocyte sedimentation rate

394

1.63

3.44

1.1

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

546

1.53

3.37

2.7

2.2

mmol/l

106.0

105.5

0.52

536

(3041354) Potassium [Moles/volume] in Venous blood

546

1.53

3.37

2.7

2.2

mmol/l

4.0

0.56

536

(3003181) Sodium [Moles/volume] in Urine

114

800

1.43

3.36

1.8

1.4

mmol/l

64.5

65.6

0.09

630

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

288

2319

1.25

3.33

4.0

3.1

0.7

1.21

276

2225

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.54

3.29

1.2

1.1

pmol/l

6.6

5.2

—

(3022313) Gas panel - Capillary blood

294

2379

1.25

3.26

5.3

3.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

400

1.61

3.26

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

311

1.68

3.15

1.5

1.3

u/l

230.8

337.0

1.09

288

(3004451) EKG impression Narrative

230

1.79

3.10

1.4

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

332

0.39

3.10

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

138

1017

1.36

3.09

1.1

125.0

114.9

3.48

128

935

(4306422)

143

1060

1.36

3.09

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

174

1334

1.31

3.00

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

287

1.68

2.93

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

565

1.47

2.92

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

173

1334

1.30

2.88

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

258

2090

1.24

2.87

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

103

733

1.41

2.87

6.5

7.0

mg/l

11.7

11.2

0.55

681

(3027923) C peptide [Moles/volume] in Serum or Plasma

312

1.64

2.87

1.3

1.7

nmol/l

1.3

0.04

248

(3020891) Body temperature

253

2046

1.24

2.86

4.6

5.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

275

1.68

2.82

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.34

2.81

1.9

1.6

—

(3022621) pH of Urine by Test strip

413

3514

1.19

2.80

2.9

2.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.27

2.76

1.5

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.27

2.76

2.0

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

215

2679

0.80

2.76

1.6

1.7

mg/l

3.3

3.7

0.53

155

1849

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

240

1.71

2.73

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1596

14834

1.10

2.70

3.5

3.4

mg/l

482.8

403.1

0.26

1097

9695

(3022493) Free Hemoglobin [Mass/volume] in Plasma

258

1.67

2.63

6.8

6.9

mg/l

4830.8

67.1

0.49

183

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

289

1.63

2.62

2.2

1.6

—

(3045414) Leukocytes [Presence] in Urine

298

2478

1.21

2.61

1.8

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.15

2.55

2.4

2.7

—

(3017704) Immunofixation for Urine

253

1.66

2.54

1.9

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

323

1.58

2.53

2.1

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

253

2077

1.23

2.53

5.3

3.9

mmol/l

24.5

24.7

0.58

238

1941

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

339

1.57

2.53

1.2

1.1

u/ml

9.6

18.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.49

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.49

1.8

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

128

969

1.33

2.48

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1595

14883

1.09

2.46

1.7

1.6

mmol/l

1.4

0.99

1361

12782

(3034891) Synovial lining cells/100 cells in Synovial fluid

263

1.64

2.46

1.7

1.5

4.5

3.6

0.16

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

102

2.06

2.46

1.8

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

248

1.66

2.45

1.6

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

211

1.71

2.42

1.8

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1660

15530

1.09

2.41

4.4

4.1

mg/mmol

7.7

10.0

1.53

1125

10250

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

481

1.46

2.41

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

467

4069

1.16

2.40

2.5

2.2

ug/l

6.6

8.1

0.96

419

3638

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

683

1.38

2.38

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

346

4049

0.85

2.37

1.4

2.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

483

1.45

2.36

1.7

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

218

1777

1.23

2.36

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

426

1.48

2.36

1.1

ratio

1.0

1.03

153

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

191

1.73

2.32

1.7

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

968

10566

0.90

2.29

2.8

2.7

ug/l

0.7

0.12

620

6380

(21494755) Public health laboratory ask at order entry panel

777

8575

0.90

2.26

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

178

1.74

2.25

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

522

1.42

2.24

1.7

2.1

74.0

73.2

0.20

500

(3045683) HLA typing for celiac disease panel - Blood or Tissue

424

1.47

2.21

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

287

1.57

2.21

2.2

1.6

—

(3028300) Cannabinoids [Presence] in Urine

352

4080

0.86

2.17

1.4

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

459

1.44

2.17

2.1

2.0

—

(3049717) Cytology report of Urine Cyto stain

212

1741

1.22

2.17

2.3

2.5

—

(4198724)

464

0.58

2.16

1.5

3.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

151

1.79

2.15

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

362

1.50

2.13

1.2

—

(3027008) Opiates [Presence] in Urine

352

4073

0.86

2.13

1.4

2.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5664

57656

0.93

2.12

3.7

3.6

mmol/l

1.3

0.03

5318

54061

(3016879) Cocaine [Presence] in Urine

324

3772

0.85

2.12

1.4

2.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

512

1.41

2.11

1.7

2.1

10.1

14.2

1.82

256

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.70

2.10

1.6

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

2.45

2.10

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

136

1066

1.28

2.10

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

986

0.72

2.09

4.1

5.4

umol/l

323.0

366.7

1.84

862

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

589

1.38

2.09

2.5

2.1

mg/l

22.0

22.7

0.03

161

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

316

2705

1.18

2.08

11.2

10.3

mmol/l

23.8

24.2

1.70

298

2546

(3027944) Amphetamines [Presence] in Urine

347

4010

0.86

2.07

1.4

2.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.26

2.07

2.1

2.0

umol/l

1.2

1.3

0.24

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

5.00

2.07

1.0

u/field

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

489

1.41

2.06

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

261

1.57

2.05

1.4

1.3

titre

70.0

66.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

399

1.46

2.03

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

425

1.44

2.01

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

436

3838

1.14

1.99

3.1

2.9

ng/l

198.0

168.7

0.58

390

3425

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

493

1.40

1.98

1.8

1.5

31.9

31.3

0.05

308

(3036603) Volume of Urine

352

1.48

1.98

1.8

1.5

1878.4

2098.9

—

(3006270) Folate [Moles/volume] in Blood

452

1.42

1.97

1.2

1.1

nmol/l

364.9

385.1

0.36

409

(4034850)

225

1882

1.20

1.94

9.8

8.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

203

0.44

1.94

1.2

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

364

1.46

1.90

1.4

1.5

u/l

5.6

6.7

0.82

315

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

299

1.51

1.89

2.3

1.4

u/ml

16.9

19.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

269

3144

0.85

1.88

1.4

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

302

1.49

1.81

1.1

1.4

nmol/l

142.0

136.3

0.37

302

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.05

1.80

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

974

1.27

1.79

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.76

1.79

2.5

2.9

—

(3011985) Renin [Units/volume] in Plasma

100

772

1.30

1.78

1.5

mu/l

58.9

63.1

0.12

695

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.17

1.77

1.1

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

513

1.37

1.77

1.4

1.3

nmol/l

1.5

1.4

0.16

457

(3044927) Protein electrophoresis panel - Urine

420

1.41

1.77

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

216

1.58

1.75

1.6

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

102

1.86

1.75

1.3

1.1

ng/l

40.7

59.0

—

(3000012) Reticulocyte production index

257

1.52

1.72

1.4

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.92

1.72

1.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.85

1.71

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

345

0.58

1.68

4.0

3.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

391

1.41

1.67

2.5

2.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

344

0.58

1.67

8.1

6.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

631

1.32

1.67

1.9

1.6

52.2

57.0

0.49

398

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

157

1.66

1.65

1.2

1.4

nmol/l

160.4

126.2

0.34

119

(3025130) Human papilloma virus identified in Specimen

112

888

1.27

1.64

2.0

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.98

1.64

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

120

1489

0.80

1.62

1.1

u/ml

7.3

6.3

0.22

807

(3047189) Immunofixation for 24 hour Urine

214

1.54

1.59

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

128

1036

1.24

1.59

1.4

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

1803

17175

1.07

1.58

3.3

mmol/l

8.5

8.2

1.47

1559

14741

(3045424) Erythrocytes [Presence] in Urine

117

938

1.25

1.58

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

376

3338

1.13

1.57

2.2

2.4

u/l

5272.0

6054.9

0.18

134

1314

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

594

1.32

1.57

1.4

mmol/l

11.3

12.2

0.36

139

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.20

1.56

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1371

14504

0.93

1.56

3.9

3.7

21.5

21.6

0.15

625

6177

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

272

1.47

1.55

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

364

1.40

1.54

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

153

1.64

1.52

1.1

—

(3048879) Bone marrow aspiration report

123

1.71

1.50

1.6

2.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

136

1649

0.82

1.50

1.1

u/ml

1.2

1.7

0.37

699

(40768806) Pleura Pathology biopsy report

453

0.66

1.48

1.4

1.6

—

(1761868) Lipid panel - Serum or Plasma

2341

24317

0.95

1.48

2.6

2.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.22

1.46

2.0

5.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

270

2358

1.15

1.46

1.8

1.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.37

1.45

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

171

1.58

1.45

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

172

1.57

1.42

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

117

1428

0.82

1.39

1.1

u/ml

0.4

1.4

3.61

636

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

721

1.27

1.39

1.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

1.71

1.38

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.20

1.36

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.20

1.36

1.0

1.6

umol/24h

237.7

327.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

129

1066

1.21

1.36

1.2

1.1

au/ml

10.3

12.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

161

0.50

1.35

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

1.49

1.35

2.3

2.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.78

1.32

1.1

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

274

1.43

1.32

1.2

1.6

u/field

1.5

3.5

1.47

205

(3039443) Prostate specific Ag panel - Serum or Plasma

112

1363

0.82

1.31

1.5

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

1.54

1.31

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.30

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.84

1.29

1.1

1.2

83.8

57.9

—

(3016750) Collection duration of Urine

326

1.38

1.29

2.7

2.2

min

512.4

494.1

0.64

253

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

164

1396

1.18

1.27

1.4

—

(3045788) Cell count panel - Pleural fluid

412

0.68

1.25

1.3

1.5

—

(3019977) pH of Arterial blood

278

1.41

1.24

2.3

3.1

7.4

0.40

(3042111) Morphology [Interpretation] in Bone marrow Narrative

806

1.23

1.4

1.7

—

(3037121) Protein [Mass/volume] in Urine

215

1876

1.15

1.22

3.3

3.4

g/l

0.3

0.4

0.21

112

873

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

126

1052

1.20

1.22

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

390

1.34

1.22

1.0

1.1

iu/ml

11.5

9.6

0.13

110

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

296

1.39

1.21

1.7

2.3

umol/l

76.2

159.2

2.33

149

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

198

2274

0.87

1.20

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

289

2577

1.13

1.19

1.3

miu/ml

238.6

223.6

0.26

124

1219

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1.47

1.19

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

197

1.47

1.19

2.4

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

666

1.25

1.18

1.1

—

(3011288) Drugs identified in Urine by Screen method

239

2705

0.88

1.18

1.8

3.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

199

2279

0.87

1.17

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

198

2268

0.87

1.17

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.93

1.16

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

126

0.48

1.16

2.7

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1013

9581

1.07

1.13

1.7

1.8

1.4

0.11

883

8600

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

200

2280

0.87

1.12

1.4

—

(3016038) Potassium [Moles/volume] in Urine

319

1.35

1.10

1.7

1.2

mmol/l

30.8

36.5

1.08

288

(3040151) Glucose [Moles/volume] in Capillary blood

592

1.25

1.10

6.8

6.3

mmol/l

7.1

7.3

0.13

495

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.95

1.08

1.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

205

1802

1.14

1.08

2.0

1.9

pmol/l

205.2

202.7

0.13

198

1716

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

144

1.53

1.08

1.2

1.1

76.3

75.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

120

1.58

1.08

1.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

350

3851

0.90

1.08

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

142

1215

1.17

1.07

2.3

2.1

—

(3021788) Differential panel - Synovial fluid

116

976

1.19

1.07

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

192

0.57

1.05

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

392

1.30

1.05

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

419

1.29

1.04

2.6

2.3

800.8

639.0

1.24

301

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

162

1.48

1.03

1.0

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

209

1847

1.14

1.03

2.2

2.5

ug/l

251.6

520.2

2.74

190

1727

(3050129) First trimester maternal screen panel - Serum or Plasma

256

2855

0.89

1.03

1.5

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

106

1.61

1.02

1.4

2.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

315

1.34

1.02

1.1

94.8

94.9

0.01

259

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6016

60746

0.95

1.01

4.4

4.3

mmol/l

2.8

5.82

5643

57023

(3001019) Free T4 and TSH panel - Serum or Plasma

377

4114

0.91

1.00

1.5

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

360

1.31

1.00

1.2

1.4

ug/l

6.7

7.3

0.18

315

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

727

1.21

1.00

1.5

1.4

pmol/l

341.2

301.7

0.49

557

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

466

1.27

1.00

3.9

4.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.00

1.00

1.3

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.00

1.00

1.7

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.80

0.98

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

167

1904

0.87

0.97

1.5

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.96

0.0

1.2

—

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.96

0.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

658

1.22

0.96

1.1

—

(40768446) Kidney Pathology biopsy report

293

1.33

0.95

1.8

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

410

0.73

0.94

1.8

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

769

1.20

0.94

1.8

1.6

—

(3005033) Fetal Nuchal fold Thickness US

162

1845

0.88

0.93

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5914

59703

0.95

0.91

4.0

3.9

mmol/l

1.4

1.64

5578

56191

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

126

1.51

0.91

2.9

3.8

u/l

93.0

100.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1030

9824

1.06

0.90

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.3

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

969

0.83

0.88

1.0

1.1

u/ml

0.3

0.6

0.28

217

(3027456) Digoxin [Moles/volume] in Serum or Plasma

656

1.21

0.88

3.2

3.1

nmol/l

0.8

0.29

496

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

177

1.41

0.88

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.65

0.87

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

168

0.59

0.86

1.9

2.1

umol/l

14.2

15.8

—

168

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.72

0.86

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.36

0.85

1.2

116.4

105.8

0.82

204

(4010399)

418

3879

1.08

0.84

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

121

1394

0.87

0.84

1.1

u/ml

0.7

2.1

4.14

351

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

145

1.45

0.84

1.2

76.8

66.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.78

0.84

1.0

1.2

u/l

40.0

12.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

213

1.36

0.84

1.2

103.8

88.5

1.35

103

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

587

1.21

0.84

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

164

1849

0.88

0.83

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

457

0.76

0.83

1.3

1.5

e6/l

14338.5

80048.8

2.55

266

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

222

2459

0.90

0.83

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

605

5695

1.07

0.83

2.2

nmol/l

13.3

13.2

0.17

552

5130

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.88

0.81

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

223

1.35

0.81

1.2

1.1

101.3

89.7

2.72

108

(40768795) Lymph node Pathology biopsy report

519

1.22

0.78

1.2

—

(3000492) Spirometry study

686

6501

1.06

0.78

1.5

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.59

0.78

14.2

6.8

58.8

71.0

—

(40768800) Prostate Pathology biopsy report

998

0.85

0.77

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

165

1.40

0.77

2.3

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

165

1.40

0.77

2.3

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

140

1235

1.14

0.77

1.6

e6/l

9184.9

13975.2

1.46

107

889

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

963

0.85

0.75

1.3

1.4

mmol/l

6.8

7.0

0.36

701

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

132

1.44

0.75

1.0

1.1

—

(4211845)

270

1.30

0.75

2.2

2.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

235

1.32

0.75

1.1

—

(3012441) Differential panel - Pleural fluid

448

0.78

0.74

1.3

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

116

1014

1.15

0.74

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

462

4332

1.07

0.74

2.3

au/ml

26.3

21.2

0.34

285

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

179

1609

1.12

0.73

1.2

1.4

mg/l

505.9

505.0

0.01

174

1529

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

316

1.27

0.73

1.5

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

136

0.59

0.72

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

552

1.20

0.72

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

382

3561

1.08

0.72

1.3

1.4

iu/l

28.4

25.0

1.09

331

3037

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

168

1.37

0.71

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.75

0.71

1.1

1.7

umol/l

39.6

45.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1083

0.87

0.70

1.1

u/ml

5.1

4.4

0.16

446

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.55

0.69

1.6

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

239

1.30

0.68

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

239

1.30

0.68

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

464

1.21

0.68

1.3

1.4

e6/l

265632.5

75566.0

0.60

328

(3002619) Bacteria identified in Specimen by Culture

110

1.46

0.68

1.5

1.2

—

(21494434) Karyotype in Bone marrow

428

1.22

0.68

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

157

1410

1.12

0.67

1.2

1.3

mmol/l

3.8

3.7

0.20

144

1327

(3013637) Mi-2 Ab [Presence] in Serum

136

1.40

0.66

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

136

1.40

0.66

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

136

1.40

0.66

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

136

1.40

0.66

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

484

0.80

0.66

1.7

2.8

—

(3034426) Prothrombin time (PT)

259

1.28

0.65

1.4

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.59

0.65

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

103

1170

0.88

0.64

1.1

u/ml

2.6

3.9

0.80

469

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

441

1.20

0.63

2.5

3.0

—

24.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

146

1.37

0.63

1.0

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.52

0.62

2.3

2.4

pmol/l

53.3

69.7

0.54

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

351

1.23

0.62

5.0

7.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

261

1.27

0.62

1.6

1.8

—

(4015189)

121

1.41

0.62

1.8

2.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

479

1.19

0.62

1.5

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.59

0.61

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.61

1.4

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

498

1.19

0.61

2.1

2.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

256

0.74

0.61

1.9

2.1

ug/min

11.2

223.0

—

(4024509)

471

1.19

0.60

1.7

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

135

1212

1.12

0.60

1.9

2.4

nmol/l

1.0

0.9

0.67

119

1026

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.48

0.60

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.48

0.60

2.0

1.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1121

0.88

0.60

1.3

u/l

25.5

22.8

0.38

933

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

131

1.37

0.59

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

106

940

1.13

0.59

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.58

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

184

1.31

0.57

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

129

1160

1.11

0.57

4.5

3.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.48

0.57

3.1

1.8

ng/l

136.3

145.4

0.08

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1120

10845

1.04

0.56

2.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

182

1668

1.09

0.56

1.5

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.46

0.56

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

504

1.17

0.55

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

435

4589

0.94

0.55

1.2

iu/ml

87.1

155.3

5.74

163

1731

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

148

0.68

0.55

1.0

1.1

u/ml

0.1

5.6

—

109

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

395

1.19

0.53

2.0

2.7

35.6

41.4

0.57

132

(40757373) Influenza virus identified in Isolate

108

1.39

0.53

1.3

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.45

0.53

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

232

1.25

0.52

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

152

1.32

0.52

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

522

0.84

0.51

1.3

1.5

e6/l

2522.1

2708.4

0.12

376

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

296

1.22

0.51

2.2

2.4

ug/l

25.6

191.3

0.95

273

(4281824)

510

0.84

0.50

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

370

1.19

0.50

1.5

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

127

1.34

0.49

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

420

3994

1.05

0.49

1.3

au/ml

60.7

47.5

0.44

163

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

201

0.75

0.49

1.9

2.8

umol/l

29.2

28.9

—

144

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

107

0.65

0.48

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.52

0.48

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

141

1292

1.09

0.46

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.43

0.46

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

176

0.74

0.45

2.2

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.62

0.45

1.2

3.6

umol/l

18.1

44.0

—

(3042517) Benzodiazepines panel - Urine

118

0.68

0.45

1.9

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

356

1.18

0.45

1.6

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.45

0.44

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

275

2596

1.06

0.43

1.7

1.8

nmol/l

38.3

38.9

0.18

270

2529

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.61

0.43

1.2

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.61

0.43

1.0

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

471

1.15

0.42

1.3

u/ml

0.6

0.7

0.07

186

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

131

1.30

0.42

1.2

pmol/l

238.7

288.2

0.34

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

149

1.28

0.41

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

149

1.28

0.41

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

149

1.28

0.41

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.38

0.41

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

7.0

—

0.2

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.4

—

25.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.39

0.40

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

370

1.16

0.40

1.1

nmol/l

0.7

6.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

1.29

0.40

13.1

5.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.40

0.0

1.3

—

18.7

—

(3006462) Nitrate [Presence] in Urine

241

1.20

0.40

2.3

2.9

—

(3017509) Phencyclidine [Presence] in Urine

104

0.67

0.39

1.1

1.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.39

0.0

1.4

—

3.0

—

(1002224) Polysomnography panel

303

3184

0.95

0.38

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.38

0.38

1.3

1.4

—

97.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

859

8833

0.97

0.38

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.38

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

252

1.19

0.37

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

660

6395

1.04

0.36

7.7

6.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

173

1621

1.07

0.36

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

267

2538

1.05

0.35

2.4

2.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

583

1.12

0.35

1.0

1.1

mg/l

225.3

259.2

1.57

513

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

0.74

0.35

1.9

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

231

2189

1.06

0.35

1.7

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

1.30

0.33

2.8

3.0

u/l

754.8

1858.7

0.65

(3038177) Helicobacter pylori Ab [Presence] in Serum

106

1146

0.92

0.33

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

155

0.77

0.33

1.9

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.70

0.33

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.68

0.33

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.67

0.33

1.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

137

1280

1.07

0.32

2.8

2.5

ug/min

88.4

129.4

0.64

834

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

606

1.11

0.32

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

581

5991

0.97

0.32

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

1186

0.93

0.32

1.4

1.5

nmol/l

0.4

0.04

957

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5696

57222

0.98

0.30

4.0

mmol/l

5.8

0.09

5285

53128

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

362

1.13

0.30

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

141

1324

1.07

0.30

1.3

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

129

1.24

0.30

1.4

1.2

g/l

37.7

38.4

0.07

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

601

1.10

0.29

1.1

1.2

mg/l

43.1

40.3

0.19

500

(3003129) Base excess in Capillary blood by calculation

112

1.25

0.28

1.4

1.8

mmol/l

-1.7

0.7

0.94

105

(3001556) Androgen free Index in Serum or Plasma

103

1.26

0.28

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

669

0.91

0.28

1.3

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

354

0.88

0.27

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

105

1123

0.93

0.27

1.2

1.3

ug/l

2.4

4.0

3.17

1032

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

122

1.23

0.27

1.0

—

(4146454)

509

1.10

0.26

2.3

2.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

243

1.15

0.26

1.1

1.2

g/l

0.3

0.48

192

(3000060) B lymphocytes [#/volume] in Blood

215

1.16

0.26

1.6

2.1

e6/l

207.1

166.6

0.25

113

(3012494) Peanut IgE Ab [Units/volume] in Serum

225

0.84

0.26

1.0

1.1

u/ml

0.3

2.6

—

129

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.30

0.26

3.4

2.8

—

(3020491) Glucose [Moles/volume] in Blood

443

1.11

0.26

1.6

1.7

mmol/l

7.0

6.3

0.94

319

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

742

7256

1.03

0.26

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.25

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1801

18240

0.98

0.25

4.3

4.2

ug/l

2.1

2.6

1.46

1624

16571

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5983

60040

0.98

0.25

4.2

4.0

mmol/l

4.7

4.41

5668

56724

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

234

0.85

0.24

1.1

—

(4027681)

474

1.10

0.24

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

161

1.18

0.24

2.2

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

124

1.21

0.24

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

110

1037

1.06

0.23

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

351

1.11

0.23

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

150

1428

1.05

0.23

1.2

1.4

e6/l

94.8

22.3

0.46

117

1098

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

150

1428

1.05

0.23

1.3

1.5

e6/l

784.3

3560.5

0.54

125

1161

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

209

1.15

0.22

2.4

2.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

1.1

u/ml

0.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.25

0.22

1.4

1.2

—

2.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

462

0.91

0.22

2.6

3.6

mu/l

40.1

29.9

0.56

439

(3051593) INR in Capillary blood by Coagulation assay

191

1.15

0.21

4.3

10.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

6.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

315

1.11

0.21

1.0

ng/l

304.4

316.0

0.14

226

(3021387) Prolactin [Units/volume] in Serum or Plasma

293

3024

0.97

0.21

1.5

1.6

mu/l

285.7

295.9

0.24

265

2732

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.16

0.21

1.4

2.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

584

0.92

0.20

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

687

0.93

0.20

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.20

0.0

1.1

—

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.20

0.0

1.1

—

(4133840)

208

0.87

0.20

1.4

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.20

0.19

1.2

mg/l

6.8

9.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.20

0.19

1.0

1.3

mmol/l

7.9

5.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5350

53695

0.99

0.19

5.3

5.0

mmol/mol

38.9

0.10

5043

50532

(3050794) Legionella sp Ab [Presence] in Serum

1.18

0.19

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

654

0.93

0.19

1.5

1.6

mmol/l

7.2

7.6

0.72

401

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

222

1.13

0.19

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.13

0.18

1.3

1.4

75.6

70.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

487

0.92

0.18

1.2

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

196

1893

1.04

0.18

1.9

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

404

0.92

0.18

1.4

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.17

0.17

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.17

0.17

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

119

1.18

0.17

2.0

2.4

—

(3044009) aPTT.lupus sensitive (LA screen)

1.13

0.17

1.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

224

1.12

0.17

1.2

g/l

—

0.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

359

1.09

0.16

1.1

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

607

0.94

0.16

1.6

1.5

promille

1.1

1.4

0.83

456

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

370

0.92

0.16

1.3

1.4

mmol/l

5.3

5.6

0.96

351

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

172

0.87

0.15

1.7

2.0

e6/l

7537.1

13837.2

—

102

(3026470) Cobalt [Mass/volume] in Blood

266

0.90

0.15

2.1

ug/l

1.9

3.1

2.03

235

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.14

0.15

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.13

0.15

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

371

1.08

0.15

2.2

1.9

u/field

1.5

1.8

0.31

170

(3024263) Appearance of Synovial fluid

284

1.09

0.15

1.4

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

313

1.09

0.15

1.0

ng/l

752.9

764.3

0.05

218

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

213

2071

1.03

0.14

1.5

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

491

0.94

0.14

1.0

1.1

u/ml

0.8

2.0

0.96

121

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

315

1.08

0.13

1.0

ng/l

36.7

45.1

0.99

220

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

559

1.06

0.13

1.1

—

(4094501)

157

1524

1.03

0.12

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.12

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

255

2495

1.02

0.12

1.5

1.4

u/l

8.7

0.00

207

2038

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

646

6378

1.01

0.12

3.9

4.0

31.9

31.5

0.53

501

4574

(3020874) Milk IgE Ab [Units/volume] in Serum

473

1.06

0.12

1.0

1.1

u/ml

5.0

2.7

0.21

137

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

249

1.08

0.11

1.2

1.1

ng/l

149.9

355.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

111

1073

1.04

0.11

1.2

1.1

iu/ml

29.2

10097.9

0.64

267

(3000034) Microalbumin [Mass/volume] in Urine

503

1.05

0.11

3.6

3.1

mg/l

60.6

61.8

0.01

379

(3029396) Erythrocyte agglutination [Presence] in Blood

230

1.09

0.11

3.8

2.9

—

(3044941) Cell count panel - Synovial fluid

847

1.04

0.11

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.11

0.10

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

584

1.04

0.10

3.9

4.7

u/ml

55.1

67.8

0.16

175

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.14

0.10

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.14

0.10

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.15

0.09

5.9

7.7

—

(3016018) Differential panel - Cerebral spinal fluid

704

1.04

0.09

1.3

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.5

pmol/l

5.1

15.8

—

(3045716) Anion gap in Serum or Plasma

233

1.07

0.09

3.6

2.6

mmol/l

9.2

9.4

0.07

174

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.09

0.08

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

136

1.10

0.08

1.3

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.09

0.08

1.6

2.0

—

(3019174) dRVVT (LA screen)

1.09

0.08

1.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

430

4349

0.99

0.08

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.06

0.08

1.3

u/l

25.7

505.0

—

(3033799) Differential panel - Peritoneal fluid

164

0.91

0.08

2.2

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

1.09

0.07

5.9

6.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

261

2646

0.99

0.07

2.2

3.0

u/ml

45.8

44.6

0.02

254

2552

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

154

1513

1.02

0.06

2.0

iu/l

3.5

4.5

1.04

571

(3005011) Chlamydia sp Ab [Titer] in Serum

1.11

0.06

1.8

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

100

0.90

0.06

1.0

—

(44806420)

103

0.87

0.06

2.4

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

115

1174

0.98

0.06

3.7

3.2

mg/l

22.4

25.9

0.67

720

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

228

1.05

0.05

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

396

1.04

0.05

1.0

1.1

u/l

1.0

1.1

0.22

177

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

605

0.98

0.04

1.9

2.2

nmol/l

21.1

20.0

0.37

577

(3027231) Wheat IgE Ab [Units/volume] in Serum

140

0.93

0.04

1.0

1.1

—

1.7

—

(3017569) Oxygen content in Arterial blood

219

1.05

0.04

2.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.10

0.04

1.0

1.1

—

(44813793)

477

1.03

0.04

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

391

3888

1.01

0.03

3.3

3.4

pmol/l

4.6

4.5

0.06

353

3484

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

847

1.02

0.03

1.2

1.3

u/l

34.1

38.2

0.16

738

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

491

0.98

0.03

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

993

0.99

0.03

1.2

1.6

—

(40758292) HTLV I+II Ab panel - Serum

122

1.07

0.02

1.2

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

128

0.94

0.02

1.1

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

142

1.06

0.02

1.4

2.7

ng/l

106.4

125.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

138

1367

1.01

0.02

1.7

—

(3008295) Osmolality of Serum or Plasma

550

1.02

0.02

1.3

1.5

mosm/kgh2o

280.3

281.5

0.11

429

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

222

1.04

0.02

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

107

0.93

0.02

7.2

7.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

102

1029

0.99

0.01

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

702

1.01

0.01

1.2

1.3

pmol/l

94.6

115.1

0.17

202

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

220

2191

1.00

0.01

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

757

0.99

0.01

1.1

—

17.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

280

2806

1.00

0.00

2.0

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

473

4736

1.00

0.00

1.8

1.9

—

(3035880) pH of Pleural fluid

233

0.99

0.00

1.3

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

247

1.01

0.00

2.5

2.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

106

1.04

0.00

1.0

1.3

mg/l

0.3

134.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

134

0.97

0.00

5.8

7.0

—

(40768793) Breast Pathology biopsy report

109

1086

1.00

0.00

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

132

0.98

0.00

1.0

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

172

0.99

0.00

1.0

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.00

0.00

2.4

2.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.94

0.00

1.8

2.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.97

0.00

2.0

1.6

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.98

0.00

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.2

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(4038314)

0.95

0.00

1.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

38.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.89

0.00

12.1

11.2

mmol/l

5.6

6.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(44806071)

0.93

0.00

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_UC_STRICT2 and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_UC_STRICT2	1.017 [0.9, 1.15]	0.782
Birth year	0.995 [0.99, 1.0]	0.231

During the follow-up period (1.1.1998 — 31.12.2019), 854 out of 14198 females with K11_UC_STRICT2 died.

Males

Parameter	HR [95% CI]	p-value
K11_UC_STRICT2	0.958 [0.87, 1.06]	0.399
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1501 out of 17157 males with K11_UC_STRICT2 died.

Mortality risk

Mortality risk for people of age

years, who have K11_UC_STRICT2.

N-year risk	Females	Males
1	0.098%	0.165%
5	0.541%	1.007%
10	1.374%	2.582%
15	2.774%	4.897%
20	4.964%	8.31%

Relationships between endpoints

↥

Index endpoint: K11_UC_STRICT2 – Ulcerative colitis (strict definition, require KELA, min 2 HDR)

GWS hits: 53

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints